DWP
ZBH icon

Daymark Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Daymark Wealth Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Sell
4,503
-1,233
-21% -$108K 0.01% 551
2026
Q1 		$519K Sell
5,736
-37
-0.6% -$3.4K 0.02% 414
2025
Q4 		$519K Sell
5,773
-103
-2% -$9.77K 0.02% 383
2025
Q3 		$579K Sell
5,876
-956
-14% -$94.7K 0.02% 355
2025
Q2 		$623K Sell
6,832
-200
-3% -$19.3K 0.02% 318
2025
Q1 		$796K Sell
7,032
-304
-4% -$32.5K 0.03% 272
2024
Q4 		$775K Buy
7,336
+89
+1% +$9.55K 0.03% 268
2024
Q3 		$782K Sell
7,247
-84
-1% -$9.17K 0.03% 276
2024
Q2 		$796K Buy
7,331
+8
+0.1% +$943 0.04% 270
2024
Q1 		$966K Buy
7,323
+449
+7% +$56.1K 0.05% 203
2023
Q4 		$837K Sell
6,874
-13
-0.2% -$1.45K 0.05% 201
2023
Q3 		$773K Buy
6,887
+4,030
+141% +$512K 0.05% 195
2023
Q2 		$416K Buy
+2,857
New +$388K 0.03% 256

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Daymark Wealth Partners's ZBH Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Zimmer Biomet (ZBH) stake by 21% in Q2 2026, selling an estimated $108K and leaving 4,503 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #551.

Daymark Wealth Partners first reported a position in ZBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $966K in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Daymark Wealth Partners held 4,503 shares of Zimmer Biomet worth $388K as of Q2 2026.
  • Daymark Wealth Partners sold 1,233 Zimmer Biomet shares in Q2 2026, an estimated $108K.
  • Zimmer Biomet made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #551 holding.
  • Daymark Wealth Partners first reported a position in Zimmer Biomet in Q2 2023 and has held it in 13 quarters since.
  • Daymark Wealth Partners's Zimmer Biomet position peaked at $966K in Q1 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.